Panagora Asset Management Inc. increased its position in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 10.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 210,905 shares of the company’s stock after purchasing an additional 20,181 shares during the quarter. Panagora Asset Management Inc. owned 0.09% of HCA Healthcare worth $98,463,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently added to or reduced their stakes in HCA. Palisade Asset Management LLC acquired a new position in HCA Healthcare in the third quarter worth $26,000. Holos Integrated Wealth LLC acquired a new position in HCA Healthcare in the fourth quarter worth $29,000. Ares Financial Consulting LLC acquired a new position in HCA Healthcare in the fourth quarter worth $31,000. JPL Wealth Management LLC acquired a new position in HCA Healthcare in the third quarter worth $33,000. Finally, Aventura Private Wealth LLC acquired a new position in shares of HCA Healthcare during the fourth quarter valued at $34,000. Institutional investors and hedge funds own 62.73% of the company’s stock.
HCA Healthcare Stock Up 0.0%
HCA stock opened at $387.25 on Monday. The company has a 50-day simple moving average of $429.60 and a 200 day simple moving average of $473.29. HCA Healthcare, Inc. has a fifty-two week low of $330.00 and a fifty-two week high of $556.52. The company has a market capitalization of $85.91 billion, a P/E ratio of 13.32, a PEG ratio of 1.23 and a beta of 1.12.
HCA Healthcare Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be given a $0.78 dividend. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 annualized dividend and a yield of 0.8%. HCA Healthcare’s payout ratio is 10.73%.
Wall Street Analyst Weigh In
Several brokerages have recently issued reports on HCA. Oppenheimer reduced their price target on shares of HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating for the company in a report on Monday, April 27th. KeyCorp reduced their price target on shares of HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating for the company in a report on Monday, April 27th. JPMorgan Chase & Co. reduced their price target on shares of HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating for the company in a report on Tuesday, May 19th. Wells Fargo & Company reduced their price target on shares of HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating for the company in a report on Monday, April 27th. Finally, Leerink Partners reduced their price objective on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a report on Monday, April 27th. Fifteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and an average price target of $506.14.
View Our Latest Stock Report on HCA Healthcare
About HCA Healthcare
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
See Also
- Five stocks we like better than HCA Healthcare
- 3 ETFs Giving Ready-Made Access to the Discounted International Small-Cap Space
- What to Expect From Q2 Earnings as Tech Strength Broadens
- Viasat’s Orbiting Profits: Space Force Jackpot?
- Robinhood Wants a Bigger Role in IPOs—Here’s Why It Matters
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
